As of 2025-07-03, the Intrinsic Value of Israel Canada TR Ltd (ISCN.TA) is 755.58 ILS. This ISCN.TA valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 1,565.00 ILS, the upside of Israel Canada TR Ltd is -51.70%.
The range of the Intrinsic Value is (198.39) - 1,970.75 ILS
Based on its market price of 1,565.00 ILS and our intrinsic valuation, Israel Canada TR Ltd (ISCN.TA) is overvalued by 51.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (1,292.61) - 4,997.22 | (782.52) | -150.0% |
| DCF (Growth 10y) | (1,123.62) - 6,661.93 | (483.62) | -130.9% |
| DCF (EBITDA 5y) | (198.39) - 1,970.75 | 755.58 | -51.7% |
| DCF (EBITDA 10y) | (140.96) - 3,274.62 | 1,172.50 | -25.1% |
| Fair Value | 1,228.12 - 1,228.12 | 1,228.12 | -21.53% |
| P/E | 486.34 - 1,223.37 | 703.76 | -55.0% |
| EV/EBITDA | (346.26) - 952.78 | 512.74 | -67.2% |
| EPV | (1,124.48) - 91.55 | (516.47) | -133.0% |
| DDM - Stable | 329.42 - 929.00 | 629.21 | -59.8% |
| DDM - Multi | 673.37 - 1,491.47 | 929.53 | -40.6% |
| Market Cap (mil) | 4,645.53 |
| Beta | 1.62 |
| Outstanding shares (mil) | 2.97 |
| Enterprise Value (mil) | 10,780.92 |
| Market risk premium | 6.13% |
| Cost of Equity | 11.60% |
| Cost of Debt | 10.39% |
| WACC | 9.78% |